Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 45Terminated 11Withdrawn 3Unknown 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 65Gastrointestinal 14Breast 11Thoracic 8Genitourinary 7Head & Neck 5Sarcoma 4Other solid neoplasm 4Dermatologic 4CNS 2Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 541Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Hematologic Neoplasms 264Leukemia 179Myelodysplastic Syndromes 170Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma 101Lymphoma, Non-Hodgkin 94Recurrence 84Neoplasms 83Multiple Myeloma 82Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Leukemia, Myelomonocytic, Chronic 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Burkitt Lymphoma 54Leukemia, Biphenotypic, Acute 48Myeloproliferative Disorders 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Hodgkin Disease 34Lymphoma, B-Cell 32Lymphoma, B-Cell, Marginal Zone 30Leukemia, B-Cell 30Anemia, Refractory, with Excess of Blasts 30Primary Myelofibrosis 28Leukemia, Plasma Cell 23Waldenstrom Macroglobulinemia 22Neoplasm, Residual 21Leukemia, Myeloid, Chronic-Phase 21

Interventions

SLC25A33 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Ovarian Epithelial × Other hematologic neoplasm × Clear all
NCT06785077 2025-01-20

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

European Institute of Oncology

Phase NA Recruiting
157 enrolled
Classical hematologyGynecologicOther hematologic neoplasm

Carcinoma, Ovarian Epithelial, Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡